Greater reductions in C-reactive protein with rosiglitazone than with glyburide or metformin despite greater weight gain
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Conference item |
| Published: |
2007
|
| _version_ | 1797096398094598144 |
|---|---|
| author | Haffner, S Kahn, SE Zinman, B Holman, R Viberti, G Herman, W Lachin, J Kravitz, BG Heise, M |
| author_facet | Haffner, S Kahn, SE Zinman, B Holman, R Viberti, G Herman, W Lachin, J Kravitz, BG Heise, M |
| author_sort | Haffner, S |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T04:41:16Z |
| format | Conference item |
| id | oxford-uuid:d1bcfa51-9896-47bb-8b5d-e23ad5584fa2 |
| institution | University of Oxford |
| last_indexed | 2024-03-07T04:41:16Z |
| publishDate | 2007 |
| record_format | dspace |
| spelling | oxford-uuid:d1bcfa51-9896-47bb-8b5d-e23ad5584fa22022-03-27T07:58:58ZGreater reductions in C-reactive protein with rosiglitazone than with glyburide or metformin despite greater weight gainConference itemhttp://purl.org/coar/resource_type/c_5794uuid:d1bcfa51-9896-47bb-8b5d-e23ad5584fa2Symplectic Elements at Oxford2007Haffner, SKahn, SEZinman, BHolman, RViberti, GHerman, WLachin, JKravitz, BGHeise, M |
| spellingShingle | Haffner, S Kahn, SE Zinman, B Holman, R Viberti, G Herman, W Lachin, J Kravitz, BG Heise, M Greater reductions in C-reactive protein with rosiglitazone than with glyburide or metformin despite greater weight gain |
| title | Greater reductions in C-reactive protein with rosiglitazone than with glyburide or metformin despite greater weight gain |
| title_full | Greater reductions in C-reactive protein with rosiglitazone than with glyburide or metformin despite greater weight gain |
| title_fullStr | Greater reductions in C-reactive protein with rosiglitazone than with glyburide or metformin despite greater weight gain |
| title_full_unstemmed | Greater reductions in C-reactive protein with rosiglitazone than with glyburide or metformin despite greater weight gain |
| title_short | Greater reductions in C-reactive protein with rosiglitazone than with glyburide or metformin despite greater weight gain |
| title_sort | greater reductions in c reactive protein with rosiglitazone than with glyburide or metformin despite greater weight gain |
| work_keys_str_mv | AT haffners greaterreductionsincreactiveproteinwithrosiglitazonethanwithglyburideormetformindespitegreaterweightgain AT kahnse greaterreductionsincreactiveproteinwithrosiglitazonethanwithglyburideormetformindespitegreaterweightgain AT zinmanb greaterreductionsincreactiveproteinwithrosiglitazonethanwithglyburideormetformindespitegreaterweightgain AT holmanr greaterreductionsincreactiveproteinwithrosiglitazonethanwithglyburideormetformindespitegreaterweightgain AT vibertig greaterreductionsincreactiveproteinwithrosiglitazonethanwithglyburideormetformindespitegreaterweightgain AT hermanw greaterreductionsincreactiveproteinwithrosiglitazonethanwithglyburideormetformindespitegreaterweightgain AT lachinj greaterreductionsincreactiveproteinwithrosiglitazonethanwithglyburideormetformindespitegreaterweightgain AT kravitzbg greaterreductionsincreactiveproteinwithrosiglitazonethanwithglyburideormetformindespitegreaterweightgain AT heisem greaterreductionsincreactiveproteinwithrosiglitazonethanwithglyburideormetformindespitegreaterweightgain |